Evidence map›Paper›PMID 41069546›Full record

ArticleActa endocrinologica (Bucharest, Romania : 2005)

COULD THE RATE OF DECREASE IN INTRAOPERATIVE PARATHYROID HORMONE LEVEL BE A DETERMINANT OF SURGICAL TECHNIQUE IN TERTIARY HYPERPARATHYROIDISM?

G Güzel, D Sarıdemir Ünal, A Özen, Y E Saçın, N Yılmaz, A Boz, C Arıcı

Abstract read
In one paragraph

Article in Acta endocrinologica (Bucharest, Romania : 2005). The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

G GüzelAntalya Serik State Hospital, Department of General Surgery.
D Sarıdemir ÜnalAkdeniz University, Faculty of Medicine, Department of General Surgery.
A ÖzenAkdeniz University, Faculty of Medicine, Department of General Surgery.
Y E SaçınAkdeniz University, Faculty of Medicine, Department of General Surgery.
N YılmazAkdeniz University, Faculty of Medicine, Department of Endocrinology.
A BozAkdeniz University, Faculty of Medicine, Department of Nuclear Medicine, Antalya, Turkey.
C ArıcıAkdeniz University, Faculty of Medicine, Department of General Surgery.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Context: Intraoperative parathyroid hormone (IO PTH) monitoring has determinative role in surgery for tertiary hyperparathyroidism (tHPT). Objective: We tried to find out whether the extent of surgery to be performed can be dedicated via IO PTH monitoring in tHPT. Design: Renal transplantation (RTX) recipients who had been operated and followed up because of tHPT between 9/2014 and 5/2021 at our institution were retrospectively analysed. Subjects and Methods: We analysed the pre-operative and postoperative data of 41 patients with tHPT. Results: Considering IO PTH monitoring; 70% and more decrease of the hormone level leaded us favourable results (89% surgical success) regardless of the PTX method (p<0.05). We obtained the same surgical success rate (75%) in patients in whom monitoring was done and was not done. We observed high success ratios (100%) in the latter group via subtotal PTX and total PTX plus autotransplantation (AT) (p<0.05). Conclusions: In surgery for tHPT, IO PTH monitoring should be maintained. When we observe 70% or more decline in the hormone level, we can decide to finish the operation regardless of the surgical technique. If hormone level decrease is below 70%, we have to continue exploration.

Indexed as

intraoperative parathyroid hormone monitoringparathyroidectomyrenal transplantationtertiary hyperparathyroidism

Identifiers

PMID41069546
PMCPMC12506883

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.